Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Alopecia-epilepsy-pyorrhea-intellectual disability syndrome is characterized by congenital permanent alopecia universalis, intellectual disability, psychomotor epilepsy and periodontitis (pyorrhea). Total permanent alopecia and pyorrhea are invariably concomitant while intellectual disability and psychomotor epilepsy are observed in most patients. No other abnormality of nails or skin (apart from absence of hair) has been reported. Transmission is autosomal dominant.
Biomarker and diagnostic research for alopecia-epilepsy-pyorrhea-intellectual disability syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for alopecia-epilepsy-pyorrhea-intellectual disability syndrome.
244 publications have been identified in PubMed for alopecia-epilepsy-pyorrhea-intellectual disability syndrome. Research spans Epidemiology / Natural History (29%), Review / Meta-Analysis (24%), and Case Report / Case Series (20%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 70 | 29% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 5:36 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
58 |
24% |
Patient case studies | 50 | 20% |
Laboratory research | 40 | 16% |
Clinical study results | 10 | 4% |
Testing and diagnosis research | 9 | 4% |
New treatment approaches | 6 | 2% |
Other research | 1 | 0% |
Zhao Y (2026). [PMID: 41705901](https://pubmed.ncbi.nlm.nih.gov/41705901/). *Prenat Diagn*. [Review / Meta-Analysis]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *American journal of human genetics*. [Basic Science / Preclinical]
Mesina RS (2026). [PMID: 40974761](https://pubmed.ncbi.nlm.nih.gov/40974761/). *Intensive & critical care nursing*. [Epidemiology / Natural History]
Vlami K (2026). [PMID: 41751879](https://pubmed.ncbi.nlm.nih.gov/41751879/). *International journal of molecular sciences*. [Case Report / Case Series]
Ates K (2026). [PMID: 42204957](https://pubmed.ncbi.nlm.nih.gov/42204957/). *Dev Neurobiol*. [Review / Meta-Analysis]
Xu X (2026). [PMID: 42138082](https://pubmed.ncbi.nlm.nih.gov/42138082/). *J Clin Invest*. [Basic Science / Preclinical]
Hindermann M (2026). [PMID: 41729076](https://pubmed.ncbi.nlm.nih.gov/41729076/). *JCI Insight*. [Basic Science / Preclinical]
Santambrogio J (2026). [PMID: 42187194](https://pubmed.ncbi.nlm.nih.gov/42187194/). *BJPsych Open*. [Review / Meta-Analysis]
Rosenberg S (2026). [PMID: 41764026](https://pubmed.ncbi.nlm.nih.gov/41764026/). *Disability and health journal*. [Epidemiology / Natural History]
Javed K (2026). [PMID: 41347281](https://pubmed.ncbi.nlm.nih.gov/41347281/). *Annals of human genetics*. [Basic Science / Preclinical]